News
03-27-2013, 01:30 AM
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida have developed a small molecule that inhibits STAT3, a protein that causes cancer. This development could impact the treatment of several tumor types, including breast, lung, prostate and others that depend on STAT3 for survival...
More... (http://www.medicalnewstoday.com/releases/258187.php)
More... (http://www.medicalnewstoday.com/releases/258187.php)